SCHEMBL25970339

SCHEMBL25970339

O=C(NCC1CCNC1)c1cc2nc(-c3ccccc3)cc(-c3ccccc3)n2n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.60
HTT P42858 3/20 0.60
ALDH1A1 P00352 7/20 0.55
TP53 P04637 6/20 0.52
MAPT P10636 4/20 0.52
OPRK1 P41145 2/20 0.52
PAOX Q6QHF9 2/20 0.52
ADRA2A P08913 1/20 0.52
ADRA2B P18089 1/20 0.52
HTR1D P28221 1/20 0.52
HTR1B P28222 1/20 0.52
HTR2B P41595 1/20 0.52
TMEM97 Q5BJF2 1/20 0.52
SMOX Q9NWM0 1/20 0.52
HPGD P15428 6/20 0.52
LMNA P02545 3/20 0.52
NPSR1 Q6W5P4 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
TDP1 Q9NUW8 1/20 0.52
GAA P10253 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25971262 0.87 KDM4E (0.49) KDM4EHTTALDH1A1TP53MAPT
SCHEMBL4206611 0.86 KDM4E (0.70) KDM4EHTTALDH1A1TP53MAPT
SCHEMBL25969143 0.83 KDM4E (0.62) KDM4EHTTALDH1A1TP53MAPT
SCHEMBL25969153 0.83 KDM4E (0.60) KDM4EHTTALDH1A1TP53MAPT
SCHEMBL25970235 0.83 KDM4E (0.63) KDM4EHTTALDH1A1TP53MAPT
SCHEMBL25969028 0.83 KDM4E (0.60) KDM4EHTTALDH1A1TP53MAPT
SCHEMBL25969035 0.81 KDM4E (0.58) KDM4EHTTALDH1A1TP53MAPT
SCHEMBL25970230 0.81 KDM4E (0.78) KDM4EHTTALDH1A1TP53MAPT
SCHEMBL31579015 0.78 KDM4E (0.62) KDM4EHTTALDH1A1TP53MAPT
SCHEMBL25969030 0.78 KDM4E (0.56) KDM4EHTTALDH1A1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250161307-A1 PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE JANSSEN PHARMACEUTICA NV (BE) 2025-05-22 US disclosed
EP-4469454-A1 PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE Janssen Pharmaceutica NV (BE) 2024-12-04 EP disclosed
WO-2023141866-A1 PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE JANSSEN PHARMACEUTICA NV (BE) 2023-08-03 WO disclosed
WO-2023141866-A1 PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE JANSSEN PHARMACEUTICA NV (BE) 2023-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250161307-A1 PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE SMOX, SRM, SMS KDM4E 1480/4885HTT 3140/4885ALDH1A1 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.